Lactose (India) Ltd vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of Lactose (India) Ltd (LACTOSEINDIALTD) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads LACTOSEINDIALTD vs SUNPHARMA on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth20
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

19.30
P/E ratio
40.36
2.06
P/B ratio
20.07
0.00%
Dividend yield
0.84%
₹4.10
EPS
₹47.84

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

9.81%
Return on equity
16.00%
13.00%
Return on capital
21.00%
15.00%
EBITDA margin
30.00%
4.31%
Net margin
19.69%

Growth

LACTOSEINDIALTD takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

35.25%
Revenue CAGR (3Y)
10.03%
94.87%
Profit CAGR (3Y)
10.57%

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹133 Cr
Market cap
₹4.63L Cr
₹116 Cr
Revenue
₹58,462 Cr
₹5 Cr
Net profit
₹11,509 Cr
0.95
Debt / equity
0.61
Lactose (India) Ltd
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 34.8% CAGR over last 5 years", "Company's working capital requirements have reduced from 22.6 days to 18.1 days"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 11.3% over last 3 years.", "Promoters have pledged 26.1% of their holding."]
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Lactose (India) Ltd full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

LACTOSEINDIALTD vs SUNPHARMA: Share Price, Valuation & Which to Buy | DocStoX